Dr. Axelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2711 Randolph Rd
Ste 100
Charlotte, NC 28207Phone+1 704-342-1900
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Michigan Medical SchoolClass of 2003
Certifications & Licensure
NC State Medical License 2012 - 2025
MD State Medical License 2009 - 2012
TX State Medical License 2006 - 2012
Publications & Presentations
PubMed
- 1807 citationsNivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, p...Michael J. Overman, Ray McDermott, Joseph Leach, Sara Lonardi, Heinz-Josef Lenz
The Lancet. Oncology. 2017-09-01 - 117 citationsU.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell CarcinomaMichael Axelson, Ke Liu, Xiaoping Jiang, Kun He, Jian Wang
Clinical Cancer Research. 2013-05-01 - 31 citationsDelayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin "flushes".Majed A. Refaai, Theodore E. Warkentin, Michael D. Axelson, Karen Matevosyan, Ravindra Sarode
Thrombosis and Haemostasis. 2007-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
